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Background: Glycated hemoglobin (A1C) and Fasting Plasma Glucose (FPG) are the two monitoring blood glucose
tests most frequently used. However, both methods are shown to be insensitive to detect glycemic variations in
short duration periods. Therefore, we aimed to assess the effect of a short-term exercise program on glycemic levels
measured by fructosamine concentrations in type 2 diabetes patients.
Methods: Eight volunteers (51.1 ± 8.2 years) underwent a supervised exercise program during eight weeks
(3 d.wk-1, 50-60% of VO2 peak for 30–60 minutes). The body composition, VO2 peak, A1C, FPG, fructosamine and
capillary blood glucose (CBG) were evaluated. We used ANOVA - One Way for repeated measures followed by Tukey
post-hoc test and paired t test. P values <0.05 were considered significant.
Results: We found statistical differences on the concentrations of fructosamine, VO2 peak and CBG. However, A1C
and FPG showed no statistical difference. Fructosamine declined by 15% (57 μmol/L) between the beginning and
the end of the study. Individually, 50% of the sample reached the reference values for the normality in fructosamine
test. VO2 peak increased by 14.8% (3.8 ml.kg
-1.min-1) and CBG decreased on an average of 34.4% (69.3 mg/dL).
Conclusions: Fructosamine test is effective in the evaluation of glucose with type 2 diabetes patients when
undergoing a short exercise program, alternatively to the traditional A1C and FPG assessment. Our results are
relevant in clinical practice, because the significant improvement in glycemic status can help to evaluate the
inclusion of exercise as adjunct therapy to replace the prescription of additional drugs in poorly controlled patients.
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Cardiorespiratory fitnessBackground
Glycemic control is a major therapeutic goal for type 2
diabetes patients. The deleterious effects of glucotoxicity
have an important role in the progressive impairment of
insulin secretion and sensitivity, two major factors in the
pathogenesis of type 2 diabetes, which can lead to future
microvascular diseases or others complications [1].
Studies have shown that glycemic control is the key to
diabetes control, because it is associated with signifi-
cant reductions of microvascular complication rates
(retinopathy and nephropathy) and neuropathy [2].* Correspondence: pramorim@ufv.br
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stated.One way to achieve a good glycemic control is through
exercise [3] that has a well-known effect on type 2 diabetes
[4]. Thus exercise has been recommended for diabetics
because increase glucose uptake to active muscle and
decrease the risk of cardiovascular diseases [5,6].
Glycated hemoglobin (A1C) and Fasting Plasma Glucose
(FPG) are the most common analysis for monitoring blood
glucose levels [2]. However, A1C reflects a glycemic control
over a period of 2–3 months, which is too long to assess
the effectiveness of short-term exercise programs on
glycemic control [7]. Likewise, the FPG is very variable
because is influenced by the glycemic content ingested
in the diet from the previous night [8].
Fructosamine (measure of glycated proteins, specifically
albumin) has a half-life shorter than the red cell. ThereforeLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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control on period of 2–3 weeks [9]. Thus, this test is par-
ticularly useful when assessing periods of rapid change in
glycemia [10], such as those resulting from a short-term
exercise programs [9,11,12].
Therefore, we aimed to assess the effect of a short-term
exercise program on glycemic levels measured by fructosa-
mine concentrations in type 2 diabetes patients.
Methods
Patients
Patients recruitment for this study occurred through
advertisements in local media, which were selected ac-
cording to the following inclusion criteria: a) Have type
2 diabetes diagnosed by criteria of the American Diabetes
Association (ADA) [2]; b) Must not have diabetes compli-
cations (cardiovascular disease, neuropathy, retinopathy
and nephropathy); c) Must not have practiced physical
exercises with professional guidance in the last 2 months
preceding the start of the program; d) Agreed not to
do other kinds of physical exercises with professional
guidance in addition to those on the program during
the study and maintain their usual diets throughout the
intervention period.
Twenty volunteers signed up to participate in the study,
fifteen of which were approved by inclusion criteria. After a
meeting to explain all the study procedures, eleven patients
confirmed their participation. After the first week of the
study, one was excluded due to an impediment in perform-
ing physical exercise because of ulceration on the feet. Two
other gave up during the exercise program for personal rea-
sons. Finally, eight patients (average age 51.1 ± 8.2 years,
diagnosis: 5.1 ± 4.6 years ago), four of whom were women,
composed the final sample. All patients were on use of
medications since diagnosis of diabetes (metformin, insulin,
and glimepiride). No patient reported changing in his dose
of medication during the study. Though, recent study
showed that metformin did not significantly attenuate the
benefits of exercise on glycemic control or fitness [13].
All patients enrolled in this study had the approval of
their physician to practice physical exercise of moderate
intensity and signed terms of consents. The study was
approved by the Ethics Committee on Human Research
of Universidade Federal de Viçosa.
Anthropometry and body composition assessment
Anthropometric measurements were obtained at the
Human Performance Laboratory (LAPEH), by a trained
examiner. Weight, height and waist circumference mea-
surements were performed by calibrated equipment based
on the procedures described by Lohman et al. [14]. Body
mass index (BMI) was calculated and analyzed according
to guidelines of the World Health Organization (WHO)
[15]. Body composition assessment was performed by theapparatus Body Composition Analyser (BIA 310 bioim-
pedance analyzer, Biodynamics Corp.) [16].
Biochemical tests
Blood sample collection was obtained from the median cu-
bital vein after eight hours fasting by a trained biochemist.
Technique of vacuum collection tubes with EDTA-K3 was
used for hematology (A1C and Fasting Plasma Glucose)
and tubes with clot accelerator (SiO2) and gel separator
was used for serology (Fructosamine). The samples were
analyzed in the Clinical Laboratory, Division of Health, at
Universidade Federal de Viçosa. The following methods were
used for analysis: a) Glycated Haemoglobin (A1C): HPLC
(High Performance Liquid Chromatography), by the device
VARIANT II System (Bio-Rad Laboratories, Inc., USA)
with reference value (RV) for normality ≤ 6.5% [2]; b)
Fructosamine: colorimetric with reduction of nitroblue
tetrazolium (NBT) by device Modular (Roche), with RV for
normal 205–285 μmol/L and c) Fasting Plasma Glucose
(FPG): glucose oxidase method in device Cobas Mira Plus
(Roche), with RV for diabetes ≥ 126 mg/dL (7.0 μmol/L) [2].
Capillary Blood Glucose (CBG) was measured, before
and after each exercise session, by blood glucose monitor
Accu-Chek Go (Roche).
Cardiorespiratory fitness
Cardiorespiratory fitness of patients was measured by
the metabolic gas analyzer VO2000 (Medical Graphics
Corporation) and analyzed by software Aerograph 4.3
(Medical Graphics Corporation). Metabolic gas analyzer was
automatic calibrated before each test. Cardiorespiratory fit-
ness tests were performed on a cycle ergometer (ISO1000,
SCIFIT® Corporate Headquarters). All necessary precautions
for to perform cardiorespiratory fitness tests in diabetic pa-
tients (e.g. blood pressure measurement at rest and during
testing, measurement of blood glucose before and after the
test) was taken. Prior to cardiorespiratory fitness tests, pa-
tients performed an adaptation to cycle ergometer through a
warm-up five minutes. Ramp protocol was used with incre-
ments to charge by the minute; in which patients were en-
couraged to reach 85% of heart rate (HR) estimated by
HRmax. = 208 – (age × 0.7) proposed by Tanaka et al. [17].
Because we do not have the presence of a physician during
the test of cardiorespiratory fitness, for security reasons,
when 85% of maximal HR was reached, the cardiorespiratory
fitness test was interrupted and started the recovery stage.
Test data (HR and VO2) were used as a basis for the devel-
opment of individual equations to estimate peak oxygen
consumption (VO2 peak) by linear regression (SigmaPlot®
Version 11.0; Systat Software, Inc., Chicago, IL, USA) [18].
Protocol
The study lasted ten weeks, in which eight weeks were
intervention with physical exercise (Table 1). The exercises
Table 1 Drawing of the progression of the study
Weeks 1Ev 2 3 4 5Fru 6 7 8 9 10Ev
Exercise period Exercise
Intensities 50 50 55 60 60 60 60 60
Duration/session 30 40 50 60 60 60 60 60
Legend: Ev = Evaluation (Anthropometry and body composition, biochemical
and cardiorespiratory fitness tests); Fru = Fructosamie examination during
exercise intervention); Intensities = percentage of VO2 peak and Duration/
Session = Minutes.
Moura et al. Diabetology & Metabolic Syndrome 2014, 6:16 Page 3 of 6
http://www.dmsjournal.com/content/6/1/16were performed into Human Performance Laboratory, at
Universidade Federal de Viçosa, by cycle ergometers (Cycle
167, 2001, ERGO-FIT®). Physical exercises were performed
three days per week (d.wk-1) over eight weeks. Throughout
the study, duration bout ranged from 30 to 60 minutes and
intensity ranges from 50% to 60% of VO2 peak (Table 1).
Training bout was divided into three phases: warm-up,
physical exercise and cool down. The warm-up and cool
down always lasted five minutes each. Intensity control
based on VO2 peak was performed by monitoring the cor-
responding HR, through the HR monitor (Polar® RS800CX,
Finland). Patients were asked to maintain an average speed
of 20 km/h throughout the exercise and the load (watts) on
the cycle ergometer was increased up to achieve the target
HR based on the percentage of VO2 peak for the specific
bout. However, if a participant presented peripheral fatigue,
the load (watts) on the cycle ergometer was reduced and
the exercise speed has increased, in order to maintain
physiological load (HR) required. The total load of the ses-
sion (Figure 1) was calculated by the following equation:
Total load of session = Intensity × Duration [19]. Fructosa-
mine analysis was performed pre, during and post study
(Weeks 1, 5 and 10) (Table 1). We do not control foodFigure 1 Average weekly blood glucose before and after exercise sesintake of the patients and they were asked to maintain their
usual diet throughout the physical exercise period.
Statistics
All variables were approved by normality test (Shapiro-Wilk)
and Equal Variance test. Thus, results are presented as
mean (x ) and standard deviation (SD). ANOVA - One
Way for repeated measures followed by Tukey post-hoc
test was used to assess the evolution of fructosamine
during the study. For the other variables, paired t test was
used to compare the performance pre and post interven-
tion, and pre and post exercise session for the capillary
blood glucose. P values <0.05 were considered significant.
The tests were performed by the software SigmaPlot
Version 11.0 (Systat Software, Inc., Chicago, IL, USA).
Results
We found significant statistical differences on fructosamine
concentrations between the study periods (P values = 0.05;
Power of performed test = 0.85 – Figure 2), VO2 peak (Table 2)
and CBG (Figure 1) before and after exercise sessions.
Fructosamine test showed a decrease in blood concentra-
tion of 15% (57 μmol/L) between the beginning and the end
of the study, while VO2 peak showed an increase of 14.8%
(3.8 ml.kg-1.min-1). Capillary blood glucose during exercise
sessions showed an average decrease of 34.4% (69.3 mg/dL).
Anthropometric variables, body composition, A1C and
FPG showed no statistical difference between pre and post
study periods (Table 2). However, when assessing the
BMI, according to World Health Organization (WHO)
[15], the classification of the subjects were in the state
of obesity class I, confirmed by the high percentage of
body fat measured by bio impedance technique.sions and the evolution of training load.
Figure 2 Mean concentration of fructosamine pre, during and
post study.
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Evidences from this study support the use of fructosamine
test to assess the effect of a short-term exercise program
on glycemic control in type 2 diabetes patients. This test
showed a decrease of 14.2% from the first to fifth week of
the study (after three exercise weeks) and 0.8% from the
fifth to tenth week (Figure 2).
Individually, 50% of the sample reached RV. Two sub-
jects reached the RV in the fifth week and remained in
that range until the end of the study, while two others
reached the RV in the fifth week but failed to keep them
until the end of the study. These results are relevant in
clinical practice, because the significant improvement of
15% in glycemic status after eight weeks of physical exer-
cise can help to evaluate the exercise inclusion as ad-
junct therapy to replace the prescription of additional
drugs in poorly controlled patients.
Studies has recommended the use of fructosamine test
for glycemic control in short periods of monitoring, which
may occur fast changes of blood glucose levels [7,9,20-24].Table 2 Anthropometric variables, body composition,
A1C, FPG and VO2 peak of subjects pre (n = 8) and post
(n = 8) study
Pre Post
Variables x ± SD x ± SD P values
Weight (kg) 83.7 ± 17.1 83.2 ± 17.7 0.195
BMI (kg/m2) 30.2 ± 6.4 29.8 ± 6.2 0.063
Waist circumference (cm) 102.6 ± 12.0 97.5 ± 20.1 0.312
% Fat 33.4 ± 6.3 32.4 ± 5.9 0.245
Fat mass (kg) 28.6 ± 9.8 27.4 ± 9.3 0.137
A1C (%) 8.9 ± 1.6 8.3 ± 1.8 0.083
FPG (mg/dL) 192.2 ± 73.9 176.7 ± 55.1 0.459
Peak VO2 (ml.kg.min
-1) 25.7 ± 5.1 29.5 ± 6.6 0.048
Legend: BMI = Body Mass Index; % Fat. = Body Fat Percentage; A1C = Glycated
hemoglobin e FPG = Fasting Plasma Glucose. Data are showed as mean
(x ) ± Standard Deviation (SD).Raz et al. [12] investigated the influence of 12 weeks
moderate exercise on the parameters of glycemic con-
trol in type 2 diabetes patients and found a significant
reduction in the fructosamine levels. Unlike the studies
cited above, the current manuscript assessed the effect of
short-term exercise program on glycemic control measured
by fructosamine test. Taken together, results from these
studies provide evidence for the use of fructosamine test
for glycemic control short-term exercise program.
Rychlewski e Szczesniak [11] investigated the effects of
regular exercise along three weeks on fructosamine levels
in children with type 1 diabetes. They found a reduction
in the frutosamine levels, as well as increased insulin
sensitivity. Although the results presented above involve
patients with type 1 diabetes, they are quite similar to the
ones presented in the current study, involving type 2
diabetes patients. However, the improvement of glycemic
control observed could likely be maximized with the con-
tinuation of the exercise program in conjunction with new
increments in the training loads.
The importance of fructosamine test as the method of
measuring glycemic status during short-term exercise
program is most apparent when viewed in conjunction
with the evaluation of A1C and FPG (Table 2). Both
tests often used as a way of controlling the glycemic
levels, despite showing a reduction that can be consid-
ered clinically important, showed no statistically signifi-
cant differences before and after study. The traditional
tests (A1C and FPG) used in the assessment of glycemic
control showed a lower sensitivity to indicate the beneficial
changes induced by exercise, as assessed by fructosamine
test. This fact may explain unsatisfactory results of the
effect of a short-term exercise program on glycemic
control sometimes found in the literature [25,26].
In a study conducted in a developing country, the use
of fructosamine test presented itself as a good alternative
for the A1C test [27]. This test may be particularly appro-
priate for developing countries like Brazil, where the supply
of strips for blood glucose control is not accessible to type
2 diabetes patients that are not being insulinized.
After the fourth exercise week, the training load remained
unaffected (Figure 1). Because of a difficulty in generating
incremental load due to the fact that diabetic patients has a
reduced fitness [5]. However, even with the maintenance of
training load, the reduction in CBG after weekly exercise
sessions remained statistically significant (P ≤ 0.001) until
the end of the exercise program.
Evolution of training load in relation to fructosamine
test results, it appears that fructosamine concentration
(Figure 2) remained practically unchanged after the
stabilization of the workload. This fact can be explained by
the physiological adaptations triggered by the exercise
in the body and shows need of workload increases to
ensure the continuity of the beneficial effects of exercise
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of increasing training loads, after the fourth exercise
week, the subjects showed an improvement in cardiore-
spiratory fitness (Table 2). These results confirm that
the intensity used in the exercise program was adequate
to cause physiological adaptations.
The lack of alteration of anthropometric variables
and body composition presented in the current study
are corroborated by the study of Boulé et al. [28]. These
authors conducted a meta-analysis about exercise effects
on glycemic control and body mass in type 2 diabetes
patients. They found that exercise effects on glycemic
control are independent of weight loss.
The main limitations of this study were the small sample
size and the absence of a control group. These facts oc-
curred due to the difficulty in finding volunteers with type
2 diabetes without microvascular diseases or others com-
plication, able and willing to participate in a program of
controlled exercise for eight weeks. However, all variables
were approved by the normality test and present paramet-
ric distribution. Another limitation was the lack of control
over food intake, despite recommendations to maintain
their usual diets are continually enforced on all subjects
throughout the intervention period.
Thus, addition to sensitivity in detecting the effects
of a short-term exercise program on glycemic control,
fructosamine test has additional advantages. Such as
realization in any day time without the need to fasting,
low cost, as well as the fact that there are available domes-
tic monitoring devices with the validity and accuracy
evidenced in relation to laboratory tests [29]. A key aspect
to type 2 diabetes patients that should be highlighted is
the existence of studies linking the reduced fructosamine
levels with decreased cardiovascular risk and mortality
rates [10,24].
Conclusions
The results of our study support the use of fructosamine
test to assess the effect of a short-term exercise program
on glycemic control in type 2 diabetes patients. This test
showed as a good alternative compared to traditional
measures of glycemic control (A1C and FPG).
Our results are relevant in clinical practice, because
the significant improvement in glycemic status after eight
weeks of physical exercise can help to evaluate the inclusion
of exercise as adjunct therapy to replace the prescription of
additional drugs in poorly controlled patients.
Nevertheless, further studies with a larger sample, diet
control and exercise programs with constant workloads
increments should be performed to replicate the results
verified in our study.
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